Abstract
Purpose
We developed a novel echoendoscope that enables contrast harmonic imaging using ultrasound contrast agents and performed contrast-enhanced harmonic endosonography (EUS) both in vitro and in vivo.
Methods
An experimental convex-array echoendoscope equipped with a wideband transducer and a specific mode for contrast harmonic imaging was used. A Doppler phantom model was employed in in vitro experiments to determine the optimal mechanical indices for contrast harmonic imaging by the echoendoscope. In the in vivo experiments, the echoendoscope was inserted into the stomachs of dogs. The digestive organs were observed after intravenous infusion of a contrast agent, Definity, using contrast-enhanced harmonic EUS. Two patients, one with pancreatic carcinoma and one with a gastrointestinal stromal tumor (GIST), underwent contrast-enhanced harmonic EUS.
Results
In vitro experiments revealed that the optimal mechanical indices were 0.35–0.40 for intermittent imaging and 0.30 or less for real-time imaging. In the in vivo experiments, branching vessels and subsequent homogeneous distribution of the signal in the pancreatic tissue were observed. During clinical application, typical vascular patterns were observed in pancreatic carcinoma and a GIST.
Conclusion
Contrast-enhanced harmonic EUS visualized parenchymal perfusion and the fine vascular structure in digestive organs and should be a useful and powerful method for clinical investigations.
Similar content being viewed by others
References
Ding H, Kudo M, Onda H, et al. Evaluation of post-treatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001;221:721–730.
Oshikawa O, Tanaka S, Ioka T, et al. Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR 2002;178:1133–1137.
Kudo M. Contrast harmonic imaging in the diagnosis and treatment of hepatic tumors. Tokyo: Springer; 2003.
Minami Y, Kudo M, Kawasaki T, et al. Evaluation of the effectiveness of transcatheter arterial chemoembolization for hepatocellular carcinoma: value of coded phase-inversion harmonics. AJR 2003;180:703–708.
Nagase M, Furuse J, Ishii H, Yoshino M. Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 2003;22:789–795.
Takeda K, Goto H, Hirooka Y, et al. Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiologica 2003;44:103–106.
Wen YL, Kudo M, Minami Y, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR 2003;181:57–63.
Kitano M, Kudo M, Maekawa K, et al. Dynamic imaging of pancreatic diseases by contrast-enhanced coded phase-inversion harmonic ultrasonography. Gut 2004;53:854–859.
Minami Y, Kudo M, Kawasaki T, et al. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR 2004;182:1224–1226.
Ohshima T, Yamaguchi T, Ishihara T, et al. Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 2004;28:335–343.
Wen YL, Kudo M, Zheng RQ, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase inversion harmonic US. AJR 2004;182:1019–1026.
Masaki T, Ohkawa S, Amano A, et al. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 2005;103:1026–1035.
Fukuta N, Kitano M, Maekawa K, et al. Estimation of the malignant potential of gastrointestinal stromal tumors: the value of contrast-enhanced coded phase-inversion harmonic US. J Gastroenterol 2005;40:247–255.
Numata K, Ozawa Y, Kobayashi N, et al. Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol 2005;40:631–640.
Sofuni A, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using contrast imaging. J Gastroenterol 2005;40:518–525.
Inoue T, Kitano M, Kudo M, et al. Diagnosis of gallbladder diseases by contrast-enhanced phase-inversion harmonic ultrasonography. Ultrasound Med Biol 2007;33:353–361.
Zuccaro G, Sterling MJ. Endosonography in pancreatic disease: differential diagnosis. In: van Dam J, Svak MV, editors. Gastrointestinal endoscopy. New York: Saunders; 1999. p. 235–243.
DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004;141:753–763.
Gorce JM, Arditi M, Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound agents. Invest Radiol 2000;35:661–671.
Baert AL, Sartor K. Contrast media in ultrasonography. Basic principles and clinical applications. Berlin: Springer; 2005.
Rickes S, Mönkemüller K, Malfertheiner P. Echo-enhanced ultrasonography with pulse inversion imaging: a new imaging modality for the differentiation of cystic pancreatic tumours. World J Gastroenterol 2006;14:2205–2208.
Rickes S, Uhle C, Kahl S, et al. Echo enhanced ultrasound; a new valid initial imaging approach for severe acute pancreatitis. Gut 2006;53:74–78.
Kimbel KH. Regulation of ethics committees in Germany. Lancet 1994;344:398.
Ueno N, Tomiyama T, Tano S. Contrast-enhanced color Doppler ultrasonography in diagnosis of pancreatic tumor: two case reports. J Ultrasound Med 1996;15:527–530.
Bhutani MS, Hoffman BJ, Velse A, Hawes RH. Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508A (Levovist). Endoscopy 1997;29:635–639.
Hirooka Y, Naitoh Y, Goto H, et al. Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc 1997;46:166–169.
Hirooka Y, Goto H, Itoh A, et al. Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 1998;93:632–635.
Becker D, Strobel D, Bernatik T, Hahn EG. Echo-enhanced color-and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001;53:784–789.
Hocke M, Schulze E, Gottschalk P, et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006;12:46–50.
Kanamori A, Hirooka Y, Itoh A, et al. Usefulness of contrast-enhanced endoscopic ultrasonography in the differentiation between malignant and benign lymphadenopathy. Am J Gastroenterol 2006;10:45–51.
Săftoiu A, Popescu C, Cazacu S, et al. Power Doppler endoscopic ultrasonography for the differential diagnosis between pancreatic cancer and pseudotumoral chronic pancreatitis. J Ultrasound Med 2006;25:363–372.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kitano, M., Kudo, M., Sakamoto, H. et al. Preliminary study of contrast-enhanced harmonic endosonography with second-generation contrast agents. J Med Ultrasonics 35, 11–18 (2008). https://doi.org/10.1007/s10396-007-0167-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10396-007-0167-6